| Gene symbol | MSLN | Synonyms | MPF, SMRP | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mesothelin | ||||
| GTO ID | GTC2877 |
| Trial ID | NCT05166070 |
| Disease | Solid Tumor |
| Altered gene | MSLN |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | RD133 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors |
| Year | 2021 |
| Country | China |
| Company sponsor | The First Affiliated Hospital with Nanjing Medical University |
| Other ID(s) | RD133CI002 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||